Skip to main content
Premium Trial:

Request an Annual Quote

Will We Never Get Cheery News from the IP Team?

In a perspectives essay posted on Venture Beat, Sergio Garcia and Michael Davis-Wilson from law firm Fenwick & West discuss the current patent landscape in light of the Supreme Court's ruling this year in MedImmune v. Genentech, which they say "effectively paved the way for more frequent patent challenges that could disadvantage smaller companies and organizations." That's especially relevant for this field. "The post-MedImmune environment presents an acute challenge for small biotech companies and universities," the authors write. "These organizations generally have limited funds to fight patent lawsuits and might therefore face stepped-up legal attacks on their patents."

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.